{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:25:26Z","timestamp":1794673526341,"version":"4.9.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"DOI":"10.1093\/cid\/cit137","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T04:27:49Z","timestamp":1363235269000},"page":"1519-1526","source":"Crossref","is-referenced-by-count":76,"title":["Mass Distribution of Azithromycin for Trachoma Control Is Associated With Increased Risk of Azithromycin-Resistant Streptococcus pneumoniae Carriage in Young Children 6 Months After Treatment"],"prefix":"10.1093","volume":"56","author":[{"given":"Christian L.","family":"Coles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasubi","family":"Mabula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Levens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harran","family":"Mkocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayoki G.","family":"Mfinanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"key":"key\n\t\t\t\t20170623052656_CIT137C1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bjo.2008.148494","article-title":"Trachoma: global magnitude of a preventable cause of blindness","volume":"93","author":"Mariotti","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key\n\t\t\t\t20170623052656_CIT137C2","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMoa040979","article-title":"Mass treatment with single-dose azithromycin for trachoma","volume":"351","author":"Solomon","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623052656_CIT137C3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(05)67529-0","article-title":"Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study","volume":"366","author":"West","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052656_CIT137C4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.mcna.2011.03.012","article-title":"Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline)","volume":"95","author":"Zuckerman","year":"2011","journal-title":"Med Clin North Am"},{"key":"key\n\t\t\t\t20170623052656_CIT137C5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00003495-200767050-00010","article-title":"Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US","volume":"67","author":"Swainston","year":"2007","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170623052656_CIT137C6","first-page":"CD001954","article-title":"Azithromycin for acute lower respiratory tract infections","author":"Panpanich","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170623052656_CIT137C7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4269\/ajtmh.2011.11-0046","article-title":"Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children","volume":"85","author":"Coles","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623052656_CIT137C8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/INF.0b013e31824155c9","article-title":"Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children","volume":"31","author":"Coles","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170623052656_CIT137C9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2009.1266","article-title":"Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial","volume":"302","author":"Porco","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170623052656_CIT137C10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cid\/cir069","article-title":"Childhood mortality in a cohort treated with mass azithromycin for trachoma","volume":"52","author":"Keenan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052656_CIT137C11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052656_CIT137C12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/655697","article-title":"The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma","volume":"51","author":"Haug","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052656_CIT137C13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/joc.1999.11.2.107","article-title":"The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data","volume":"11","author":"Carbon","year":"1999","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20170623052656_CIT137C14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052656_CIT137C15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(09)61447-1","article-title":"3-monthly azithromycin administration for trachoma","volume":"374","author":"Malhotra-Kumar","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052656_CIT137C16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3201\/eid1106.050147","article-title":"Hidden epidemic of macrolide-resistant pneumococci","volume":"11","author":"Klugman","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170623052656_CIT137C17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052656_CIT137C18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/429242","article-title":"Predicting antimicrobial resistance in invasive pneumococcal infections","volume":"40","author":"Vanderkooi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052656_CIT137C19","article-title":"Integrated management of childhood illness. 2008","author":"World Health Organization"},{"key":"key\n\t\t\t\t20170623052656_CIT137C20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/JCM.39.3.1021-1024.2001","article-title":"Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies","volume":"39","author":"O'Brien","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170623052656_CIT137C21","volume-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard.","author":"Clinical and Laboratory Standards Institute","edition":"10th ed"},{"key":"key\n\t\t\t\t20170623052656_CIT137C22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/clinids\/24.3.356","article-title":"A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae","volume":"24","author":"Leach","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052656_CIT137C23","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.47.9.2765-2769.2003","article-title":"Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae","volume":"47","author":"Batt","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170623052656_CIT137C24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1086\/341414","article-title":"Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal","volume":"35","author":"Fry","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052656_CIT137C25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1473-3099(05)70189-4","article-title":"Antimicrobial resistance in developing countries. Part I: recent trends and current status","volume":"5","author":"Okeke","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170623052656_CIT137C26","doi-asserted-by":"crossref","first-page":"e1567","DOI":"10.1136\/bmj.e1567","article-title":"Challenges of drug resistance in the developing world","volume":"344","author":"Laxminarayan","year":"2012","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170623052656_CIT137C27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2007.04.006","article-title":"Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001\u20132004","volume":"55","author":"Felmingham","year":"2007","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170623052656_CIT137C28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.drup.2011.02.006","article-title":"The global need for effective antibiotics\u2014moving towards concerted action","volume":"14","author":"Cars","year":"2011","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170623052656_CIT137C29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3855\/jidc.1211","article-title":"When medicines fail: recommendations for curbing antibiotic resistance","volume":"4","author":"Nugent","year":"2010","journal-title":"J Infect Dev Ctries"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/56\/11\/1519\/17851248\/cit137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T21:53:51Z","timestamp":1595541231000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cit137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,3,13]]},"published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cit137","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}